3,579 results found

These advantages are not insignificant in today's patent monetization landscape.

Last week in Novartis Pharmaceutical Corp. v. Par Pharmaceutical Inc., Nos. 14-1289-RGA, 14-1494-RGA, 15-0078-RGA (D. Del. Apr. 11, 2019),

In implementing the Federal Circuit's In Re Aqua Products' holding, the Patent Trial & Appeal Board (PTAB) explains that "practice and procedure before the Board will not change."

Yesterday, the Patent Trial & Appeal Board (PTAB) designated one new precedential case, and four informative decisions directed to printed publication analyses.

Appeals from the PTAB have now become a major component of the Federal Circuit's docket. Given the deferential "substantial evidence" standard accorded PTAB decisions, upward of 60% of such appeals are simply affirmed ...

The USPTO will host a Boardside Chat webinar on Thursday, August 8, from noon to 1PM (EST) to address recent updates made to the AIA Trial Practice

The United States Patent and Trademark Office (USPTO) is increasing Patent and Patent Trial and Appeal Board (PTAB) fees for a second time in three years.

IPR estoppel under 35 U.S.C. § 315(e)(2) provides that "the petitioner in an inter partes review of a claim in a patent...

As we move into the fall season, a host of bar association programs are on the horizon from IPO, AIPLA and others. But first, a few options for PTAB focused CLE

The AIA statutes provide that a person who is not the owner of a patent, can challenge the patent at the Patent Trial & Appeal Board (PTAB).

On May 20, 2019, the U.S. Supreme Court issued an 8-1 ruling in the case of Mission Product Holdings, Inc. v. Tempnology, LLC.

On April 1, 2016, the U.S. Patent and Trademark Office (PTO) issued a series of amendments to the rules of practice for trials at the Patent Trial and Appeal Board.

As I have discussed previously, Arthrex is more of an academic exercise for constitutional and administrative law nerds scholars than anything else.

On October 30, the U.S. Department of the Treasury's Office of Foreign Assets Control ("OFAC") published an advisory to highlight sanctions risks arising from dealings in high-value artwork...

Investing in today's global market comes with its fair share of risks, with familiar concerns such as sanctions, regulatory compliance, and geopolitical issues taking centre stage.

The U.S. Court of Appeals for the Eighth Circuit recently affirmed the dismissal of a False Claims Act ("FCA") complaint in United States ex rel. Dunn v. North Memorial Health Care (8th Cir. No. 13-1099, Jan. 9, 2014) for failing to meet the particularity requirements of Rule 9(b).

On October 11, 2016, the Seventh Circuit confirmed that there is no violation of the False Claims Act ("FCA") where the defendant allegedly violated a self-imposed requirement...